Veeva Systems Stock-Based Compensation 2012-2024 | VEEV

Veeva Systems annual/quarterly stock-based compensation history and growth rate from 2012 to 2024. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors
  • Veeva Systems stock-based compensation for the quarter ending October 31, 2024 was $0.322B, a 9.26% increase year-over-year.
  • Veeva Systems stock-based compensation for the twelve months ending October 31, 2024 was $1.016B, a 9.13% increase year-over-year.
  • Veeva Systems annual stock-based compensation for 2024 was $0.394B, a 11.89% increase from 2023.
  • Veeva Systems annual stock-based compensation for 2023 was $0.352B, a 49.98% increase from 2022.
  • Veeva Systems annual stock-based compensation for 2022 was $0.235B, a 26.83% increase from 2021.
Veeva Systems Annual Stock-Based Compensation
(Millions of US $)
2024 $394
2023 $352
2022 $235
2021 $185
2020 $116
2019 $76
2018 $54
2017 $41
2016 $24
2015 $14
2014 $7
2013 $1
2012 $0
2011 $0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $37.209B $2.364B
Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company's product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data).
Stock Name Country Market Cap PE Ratio
Hims & Hers Health (HIMS) United States $15.018B 381.89
Tempus AI (TEM) United States $13.495B 0.00
Inspire Medical Systems (INSP) United States $5.303B 103.31
IRhythm Technologies (IRTC) United States $3.538B 0.00
Privia Health (PRVA) United States $3.060B 255.00
Enovis (ENOV) United States $2.533B 16.87
Clover Health Investments (CLOV) United States $2.280B 0.00
Azenta (AZTA) United States $2.075B 96.64
Schrodinger (SDGR) United States $1.895B 0.00
Omnicell (OMCL) United States $1.858B 40.53
Phreesia (PHR) United States $1.725B 0.00
10x Genomics (TXG) United States $1.465B 0.00
Butterfly Network (BFLY) United States $1.004B 0.00
Talkspace (TALK) United States $0.652B 0.00
Fulgent Genetics (FLGT) United States $0.531B 0.00
Standard BioTools (LAB) United States $0.517B 0.00
TruBridge (TBRG) United States $0.426B 124.04
Nyxoah SA (NYXH) Belgium $0.357B 0.00
Health Catalyst (HCAT) United States $0.338B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.319B 0.00
Pulmonx (LUNG) United States $0.262B 0.00
American Well (AMWL) United States $0.191B 0.00
EUDA Health Holdings (EUDA) Singapore $0.102B 0.00
MDxHealth SA (MDXH) Belgium $0.088B 0.00
P3 Health Partners (PIII) United States $0.077B 0.00
111 (YI) China $0.069B 0.00
CareCloud (CCLD) United States $0.063B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
Outset Medical (OM) United States $0.050B 0.00
Zepp Health (ZEPP) China $0.045B 0.00
SHL Telemedicine (SHLT) Israel $0.038B 0.00
Zhongchao (ZCMD) China $0.035B 0.00
Movano (MOVE) United States $0.034B 0.00
Bullfrog AI Holdings (BFRG) United States $0.028B 0.00
MSP Recovery (MSPR) United States $0.018B 0.00
Streamline Health Solutions (STRM) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Precipio (PRPO) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.008B 0.00
Tivic Health Systems (TIVC) United States $0.005B 0.00
Syra Health (SYRA) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00